Celldex Therapeutics Stock Price on September 13, 2024
| CLDX Stock | USD 26.76 1.38 4.90% |
Below is the normalized historical share price chart for Celldex Therapeutics extending back to May 15, 1986. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Celldex Therapeutics stands at 26.76, as last reported on the 27th of November, with the highest price reaching 28.33 and the lowest price hitting 26.53 during the day.
If you're considering investing in Celldex Stock, it is important to understand the factors that can impact its price. Celldex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of risk over the last 3 months. Celldex Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Celldex Therapeutics' Risk Adjusted Performance of (0.08), standard deviation of 3.77, and Mean Deviation of 2.76 to double-check the risk estimate we provide.
At this time, Celldex Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 50.9 M in 2024, whereas Capital Stock is likely to drop slightly above 40.1 K in 2024. . At this time, Celldex Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to rise to 293.12 in 2024, whereas Price Earnings Ratio is likely to drop (14.27) in 2024. Celldex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of March 2008 | 200 Day MA 36.772 | 50 Day MA 29.9178 | Beta 1.594 |
Celldex |
Sharpe Ratio = -0.1462
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLDX |
Estimated Market Risk
| 3.78 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.55 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Celldex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celldex Therapeutics by adding Celldex Therapeutics to a well-diversified portfolio.
Price Book 2.3755 | Enterprise Value Ebitda (17.34) | Price Sales 177.9642 | Shares Float 66.2 M | Wall Street Target Price 67.1 |
Related Headline
AnaptysBio Headline on 13th of September 2024
Disposition of 1300 shares by Orwin John A of AnaptysBio sub... by Orwin John A
Filed transaction by AnaptysBio Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Celldex Therapeutics Valuation on September 13, 2024
It is possible to determine the worth of Celldex Therapeutics on a given historical date. On September 13, 2024 Celldex was worth 42.16 at the beginning of the trading date compared to the closed value of 44.16. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Celldex Therapeutics stock. Still, in general, we apply an absolute valuation method to find Celldex Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Celldex Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Celldex Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 41.68 | 42.33 | 41.36 | 41.75 | 385,098 | |
09/13/2024 | 42.16 | 44.28 | 41.97 | 44.16 | 545,418 |
| 44.24 | 44.53 | 42.75 | 42.86 | 1,000,009 |
| Backtest Celldex Therapeutics | | | Celldex Therapeutics History | | | Celldex Therapeutics Valuation | Previous | Next |
Celldex Therapeutics Trading Date Momentum on September 13, 2024
| On September 16 2024 Celldex Therapeutics was traded for 42.86 at the closing time. The top price for the day was 44.53 and the lowest listed price was 42.75 . The trading volume for the day was 1 M. The trading history from September 16, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.94% . The overall trading delta against the current closing price is 6.09% . |
Celldex Therapeutics Fundamentals Correlations and Trends
By evaluating Celldex Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Celldex Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Celldex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Celldex Therapeutics Stock history
Celldex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Celldex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Celldex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Celldex Therapeutics stock prices may prove useful in developing a viable investing in Celldex Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 48.4 M | 50.9 M | |
| Net Loss | -101.1 M | -106.1 M |
Celldex Therapeutics Quarterly Net Working Capital |
|
Celldex Therapeutics Stock Technical Analysis
Celldex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Celldex Therapeutics Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Celldex Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Celldex Therapeutics November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Celldex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Celldex Therapeutics shares will generate the highest return on investment. By undertsting and applying Celldex Therapeutics stock market strength indicators, traders can identify Celldex Therapeutics entry and exit signals to maximize returns
Celldex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Celldex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Celldex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Celldex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.